Five radiation sessions tested to control prostate cancer
NCT ID NCT01517451
Summary
This study tested a shorter, more intense radiation schedule combined with temporary hormone therapy for men with intermediate-risk prostate cancer. Forty-five participants received five radiation treatments over about ten days, along with four months of medication to lower testosterone. Researchers wanted to see if this approach effectively controlled the cancer while managing side effects like urinary, bowel, and sexual function changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PROSTATE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sibley Memorial Hospital
Washington D.C., District of Columbia, 20016, United States
-
Suburban Hospital
Bethesda, Maryland, 20814, United States
-
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.